Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Beckman coulter has determined upward shift in patient and control recovery with synchron systems apolipoprotein b (apob) reagent lots m908383 and higher when used with apolipoprotein calibrator (apo cal) lots m901536 and m904505.